糖化血红蛋白A1c(HbA1c)等多因子检测试剂盒(流式荧光发光法)

Multiplex Assay Kit for Glycated Hemoglobin A1c (HbA1c) ,etc. by FLIA (Flow Luminescence Immunoassay)

Glycosylated Hemoglobin; Hemoglobin A1c; Hb1c; HbAIc; HbAIc

（注：单次混测多因子不超过8个指标 ）

  • 糖化血红蛋白A1c(HbA1c)等多因子检测试剂盒(流式荧光发光法) 产品包装(模拟)
  • 糖化血红蛋白A1c(HbA1c)等多因子检测试剂盒(流式荧光发光法) 产品包装(模拟)
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

本试剂盒用于检测糖化血红蛋白A1c(HbA1c)等多因子检测试剂盒(流式荧光发光法)，经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制，不可能完成对所有相关或相似物质交叉反应检测，因此本试剂盒有可能与未经检测的其它物质有交叉反应。

回收率

分别于定值血清及血浆样本中加入一定量的糖化血红蛋白A1c(HbA1c)等多因子检测试剂盒(流式荧光发光法)（加标样品），重复测定并计算其均值，回收率为测定值与理论值的比率。

样本 回收率范围(%) 平均回收率(%)
serum(n=5) 94-102 98
EDTA plasma(n=5) 79-98 85
heparin plasma(n=5) 96-103 99

精密度

精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差：取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次，分别计算不同浓度样本的平均值及SD值。
批间差：选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定，每个样本使用同一试剂盒重复测定8次，分别计算不同浓度样本的平均值及SD值。
批内差： CV<10%
批间差： CV<12%

线性

在定值血清及血浆样本内加入适量的糖化血红蛋白A1c(HbA1c)等多因子检测试剂盒(流式荧光发光法)，并倍比稀释成1:2，1:4，1:8，1:16的待测样本，线性范围即为稀释后样本中糖化血红蛋白A1c(HbA1c)等多因子检测试剂盒(流式荧光发光法)含量的测定值与理论值的比率。

样本 1:2 1:4 1:8 1:16
serum(n=5) 78-89% 96-103% 88-96% 79-91%
EDTA plasma(n=5) 80-95% 80-101% 88-102% 87-98%
heparin plasma(n=5) 88-95% 93-101% 79-94% 90-101%

稳定性

经测定，试剂盒在有效期内按推荐温度保存，其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响，实验室的环境条件需尽量保持一致，尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。

实验流程

1. 实验前标准品、试剂及样本准备；
2. 加样（标准品、样本、磁珠、检测溶液A）标准品或样本50μL及磁珠10μL，加检测溶液A50μL，
    37°C酶标板振荡器孵育60分钟；
3. 磁吸洗板3次；
4. 加检测溶液B100μL，37°C振动孵育30分钟；
5. 磁吸洗板3次；
6. 加鞘液100μL，旋涡震荡2分钟后读数。

实验原理

将糖化血红蛋白A1c(HbA1c)等多因子检测试剂盒(流式荧光发光法)抗体包被于磁珠，制成固相载体，向微孔中分别加入标准品或标本以及磁珠、标记VEGFA，标记的糖化血红蛋白A1c(HbA1c)等多因子检测试剂盒(流式荧光发光法)和未标记的糖化血红蛋白A1c(HbA1c)等多因子检测试剂盒(流式荧光发光法)与连接于固相载体上的抗体竞争结合，然后将未结合物洗净后，加入PE标记的亲和素，再次彻底洗涤后即可上机读数。MFI值和样品中的糖化血红蛋白A1c(HbA1c)等多因子检测试剂盒(流式荧光发光法)呈负相关。

赠品

相关产品

编号 适用物种：Homo sapiens (Human，人) 应用(仅供研究使用，不用于临床诊断！)
NPA190Hu01 糖化血红蛋白A1c(HbA1c)天然蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAA190Hu01 糖化血红蛋白A1c(HbA1c)多克隆抗体 WB; IHC; ICC; IP.
LAA190Hu71 糖化血红蛋白A1c(HbA1c)多克隆抗体(生物素标记) WB; IHC; ICC.
MAA190Hu21 糖化血红蛋白A1c(HbA1c)单克隆抗体 WB; IHC; ICC; IP.
MAA190Hu22 糖化血红蛋白A1c(HbA1c)单克隆抗体 WB; IHC; ICC; IP.
CEA190Hu 糖化血红蛋白A1c(HbA1c)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
CCA190Hu 糖化血红蛋白A1c(HbA1c)检测试剂盒(化学发光免疫分析法) Chemiluminescent immunoassay for Antigen Detection.
LMA190Hu 糖化血红蛋白A1c(HbA1c)等多因子检测试剂盒(流式荧光发光法) FLIA Kit for Antigen Detection.
KSA190Hu01 糖化血红蛋白A1c(HbA1c)检测试剂盒DIY材料(酶联免疫吸附试验法) Main materials for "Do It (ELISA Kit) Yourself".
KSA190Hu11 糖化血红蛋白A1c(HbA1c)检测试剂盒DIY材料(酶联免疫吸附试验法) Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志 参考文献
J Am Coll Nutr The Effect of Vitamin D Supplementation on Glycemic Control and Lipid Profile in Patients with Type 2 Diabetes Mellitus [PubMed: 26391639]
Journal of the American College of Nutrition The Effect of Vitamin D Supplementation on Glycemic Control and Lipid Profile in Patients with Type 2 Diabetes Mellitus. [pubmed:26391639]
Journal of Endocrinology and Metabolism Circulating Betatrophin and Hepatocyte Growth Factor in Type 2 Diabetic Patients: Their Relationship With Disease Prognosis [405]
Molecular nutrition & food research Chicory inulin ameliorates type 2 diabetes mellitus and suppresses JNK and MAPK pathways in vivo and in vitro [pubmed:28105758]
33 d-Ribose as a Contributor to Glycated Haemoglobin [pubmed:29033370]
Journal of Functional Foods Hypoglycemic effect of Hypericum attenuatum Choisy extracts on type 2 diabetes by regulating glucolipid metabolism and modulating gut microbiota []
West Indian Medical Journal Plasma Cellular Hypoxia, Mitochondrial Dysfunction, Disease Risk and Prognostic Factors in Type 2 Diabetic Patients in Saudi Arabia. []
Journal of Occupational and Environmental Hygiene Stressors, allostatic load, and health outcomes among women hotel housekeepers: A pilot study [Pubmed: 30615593]
Cell Reports Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids [Pubmed: 30605678]
Journal of Agricultural and Food Chemistry Gymnemic acid alleviates type 2 diabetes mellitus and suppresses endoplasmic reticulum stress in vivo and in vitro []
Journal of Clinical Medicine 1H Nuclear Magnetic Resonance (NMR)-Based Cerebrospinal Fluid and Plasma Metabolomic Analysis in Type 2 Diabetic Patients and Risk Prediction for Diabetic … [Pubmed: 31248127]
Food & Function Gymnemic Acid Alleviates Inflammation and Insulin Resistance via PPARδ-and NFκB-mediated pathways in db/db mice. []
Obesity Surgery Duodenal-Jejunal Bypass Ameliorates Type 2 Diabetes Mellitus by Activating Insulin Signaling and Improving Glucose Utilization in the Brain [Pubmed: 31605365]
Acta Diabetologica Modulation of gut microbiota contributes to effects of intensive insulin therapy on intestinal morphological alteration in high-fat-diet-treated mice [Pubmed: 31749050]
Open Access Macedonian Journal of Medical Sciences Inhibition of Receptor for Advanced Glycation End Products as New Promising Strategy Treatment in Diabetic Retinopathy [Pubmed: 32165929]
Cell Reports Activation of a Specific Gut Bacteroides-Folate-Liver Axis Benefits for the Alleviation of Nonalcoholic Hepatic Steatosis [Pubmed: 32783933]
The effects of different intensity endurance and resistance exercise on diabetic-related blood profiles in impaired glucose tolerance mice []
Revista Internacional de Andrologia Relation of pharmacopenile duplex ultrasonography parameters and glycated hemoglobin (HbA1c) in diabetic patients with erectile dysfunction [33334711]
Advanced Theory and Simulations? Identification of Key Contributive Compounds in a Herbal Medicine: A Novel Mathematic¡ªBiological Evaluation Approach []
Dis Markers The Roles of Liver Inflammation and the Insulin Signaling Pathway in PM2. 5 Instillation-Induced Insulin Resistance in Wistar Rats [34745386]
Antioxidants Antioxidant Effect of Tyr-Ala Extracted from Zein on INS-1 Cells and Type 2 Diabetes High-Fat-Diet-Induced Mice [Pubmed:35740008]
P001–Inv. Clínica []
留言咨询